Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin vs Probucol in Hyperlipidemic Patients With Non-Diabetic Nephropathy
NCT00276133Phase 4Completed
- Sponsor
- Yokohama City University Medical Center
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin, probucol in hyperlipidemia, chronic kidney disease (CKD), sponsored by Yokohama City University Medical Center. Started Jan 2004; status: completed.
02
Drugs
atorvastatinprobucol
03
Conditions
hyperlipidemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00276133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00276133.